Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 5.85864548 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.85864548 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.44327908 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.44327908 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 4.95969630 |
6 | negative regulation of interleukin-12 production (GO:0032695) | 4.70409627 |
7 | protein carboxylation (GO:0018214) | 4.63512304 |
8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.63512304 |
9 | tolerance induction (GO:0002507) | 4.61606437 |
10 | response to peptidoglycan (GO:0032494) | 4.54426349 |
11 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.40060309 |
12 | response to muramyl dipeptide (GO:0032495) | 4.23804017 |
13 | indole-containing compound catabolic process (GO:0042436) | 4.19881701 |
14 | indolalkylamine catabolic process (GO:0046218) | 4.19881701 |
15 | tryptophan catabolic process (GO:0006569) | 4.19881701 |
16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.17331090 |
17 | negative regulation of fibrinolysis (GO:0051918) | 4.11038341 |
18 | regulation of chronic inflammatory response (GO:0002676) | 4.07845190 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06482444 |
20 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.97144340 |
21 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.97144340 |
22 | bile acid biosynthetic process (GO:0006699) | 3.94317494 |
23 | tryptophan metabolic process (GO:0006568) | 3.91078823 |
24 | high-density lipoprotein particle remodeling (GO:0034375) | 3.88198130 |
25 | NIK/NF-kappaB signaling (GO:0038061) | 3.88002354 |
26 | urea metabolic process (GO:0019627) | 3.87539393 |
27 | urea cycle (GO:0000050) | 3.87539393 |
28 | macrophage activation involved in immune response (GO:0002281) | 3.87438366 |
29 | kynurenine metabolic process (GO:0070189) | 3.84943225 |
30 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.81983089 |
31 | regulation of fibrinolysis (GO:0051917) | 3.80429165 |
32 | acylglycerol homeostasis (GO:0055090) | 3.80328382 |
33 | triglyceride homeostasis (GO:0070328) | 3.80328382 |
34 | fibrinolysis (GO:0042730) | 3.74645045 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 3.67845252 |
36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66937531 |
37 | modulation by symbiont of host defense response (GO:0052031) | 3.66937531 |
38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66937531 |
39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66937531 |
40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66937531 |
41 | modulation by symbiont of host immune response (GO:0052553) | 3.66937531 |
42 | germinal center formation (GO:0002467) | 3.66198691 |
43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65594114 |
44 | negative regulation of cell killing (GO:0031342) | 3.65594114 |
45 | plasma lipoprotein particle clearance (GO:0034381) | 3.64843769 |
46 | regulation of protein activation cascade (GO:2000257) | 3.64755709 |
47 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.61770097 |
48 | complement activation, alternative pathway (GO:0006957) | 3.59155247 |
49 | cysteine metabolic process (GO:0006534) | 3.57761936 |
50 | regulation of cholesterol homeostasis (GO:2000188) | 3.57464477 |
51 | negative regulation of sterol transport (GO:0032372) | 3.56769618 |
52 | negative regulation of cholesterol transport (GO:0032375) | 3.56769618 |
53 | glyoxylate metabolic process (GO:0046487) | 3.56533670 |
54 | nitrogen cycle metabolic process (GO:0071941) | 3.56470751 |
55 | acute-phase response (GO:0006953) | 3.55259245 |
56 | response to protozoan (GO:0001562) | 3.52757669 |
57 | bile acid metabolic process (GO:0008206) | 3.51293888 |
58 | regulation of triglyceride catabolic process (GO:0010896) | 3.50927646 |
59 | fatty acid elongation (GO:0030497) | 3.48865110 |
60 | aromatic amino acid family metabolic process (GO:0009072) | 3.47288694 |
61 | phospholipid efflux (GO:0033700) | 3.46072269 |
62 | defense response to protozoan (GO:0042832) | 3.42945144 |
63 | regulation of cholesterol esterification (GO:0010872) | 3.42505677 |
64 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.41522238 |
65 | tyrosine metabolic process (GO:0006570) | 3.40685667 |
66 | regulation of chemokine biosynthetic process (GO:0045073) | 3.39052086 |
67 | myeloid dendritic cell differentiation (GO:0043011) | 3.38664619 |
68 | positive regulation of heat generation (GO:0031652) | 3.38432055 |
69 | regulation of complement activation (GO:0030449) | 3.37852068 |
70 | reverse cholesterol transport (GO:0043691) | 3.36023232 |
71 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33789639 |
72 | cholesterol efflux (GO:0033344) | 3.32586625 |
73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.31130041 |
74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.24287086 |
75 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23855026 |
76 | T-helper 1 type immune response (GO:0042088) | 3.23220923 |
77 | regulation of vitamin metabolic process (GO:0030656) | 3.22261832 |
78 | negative regulation of interleukin-6 production (GO:0032715) | 3.21898293 |
79 | immunoglobulin mediated immune response (GO:0016064) | 3.20444502 |
80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19335291 |
81 | neutrophil activation involved in immune response (GO:0002283) | 3.19311564 |
82 | opsonization (GO:0008228) | 3.18402238 |
83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17620925 |
84 | cellular extravasation (GO:0045123) | 3.17257562 |
85 | protein-lipid complex remodeling (GO:0034368) | 3.13883508 |
86 | macromolecular complex remodeling (GO:0034367) | 3.13883508 |
87 | plasma lipoprotein particle remodeling (GO:0034369) | 3.13883508 |
88 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.13866415 |
89 | bile acid and bile salt transport (GO:0015721) | 3.13501889 |
90 | cholesterol homeostasis (GO:0042632) | 3.12564430 |
91 | sterol homeostasis (GO:0055092) | 3.10377831 |
92 | leukocyte aggregation (GO:0070486) | 3.09882424 |
93 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.08115073 |
94 | granulocyte activation (GO:0036230) | 3.06954017 |
95 | response to type I interferon (GO:0034340) | 3.05216438 |
96 | amine catabolic process (GO:0009310) | 3.03435682 |
97 | cellular biogenic amine catabolic process (GO:0042402) | 3.03435682 |
98 | intestinal cholesterol absorption (GO:0030299) | 3.03268759 |
99 | cofactor catabolic process (GO:0051187) | 3.02957402 |
100 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.02175054 |
101 | type I interferon signaling pathway (GO:0060337) | 3.01888815 |
102 | cellular response to type I interferon (GO:0071357) | 3.01888815 |
103 | low-density lipoprotein particle clearance (GO:0034383) | 3.01806037 |
104 | regulation of bile acid biosynthetic process (GO:0070857) | 2.99203225 |
105 | regulation of fever generation (GO:0031620) | 2.98882827 |
106 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.98064713 |
107 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97189223 |
108 | myeloid dendritic cell activation (GO:0001773) | 2.96419808 |
109 | homocysteine metabolic process (GO:0050667) | 2.96082545 |
110 | heme transport (GO:0015886) | 2.95930643 |
111 | negative regulation of lipase activity (GO:0060192) | 2.94368568 |
112 | indolalkylamine metabolic process (GO:0006586) | 2.93139554 |
113 | lipoprotein metabolic process (GO:0042157) | 2.93007598 |
114 | sulfur amino acid catabolic process (GO:0000098) | 2.92297406 |
115 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92189310 |
116 | cholesterol biosynthetic process (GO:0006695) | 2.91883633 |
117 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.90122848 |
118 | coenzyme catabolic process (GO:0009109) | 2.90022526 |
119 | plasma lipoprotein particle assembly (GO:0034377) | 2.88578100 |
120 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.87276195 |
121 | regulation of T cell tolerance induction (GO:0002664) | 2.85203500 |
122 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.85058076 |
123 | myeloid cell activation involved in immune response (GO:0002275) | 2.84846435 |
124 | cellular glucuronidation (GO:0052695) | 2.84465066 |
125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84091868 |
126 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.83205256 |
127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.82235914 |
128 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.81430947 |
129 | regulation of interferon-alpha production (GO:0032647) | 2.81382782 |
130 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81160846 |
131 | protein-lipid complex assembly (GO:0065005) | 2.80561687 |
132 | macrophage activation (GO:0042116) | 2.80480052 |
133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79649772 |
134 | positive regulation of interleukin-2 production (GO:0032743) | 2.79598186 |
135 | regulation of podosome assembly (GO:0071801) | 2.79331661 |
136 | blood coagulation, intrinsic pathway (GO:0007597) | 2.79068864 |
137 | neutrophil activation (GO:0042119) | 2.78741301 |
138 | very long-chain fatty acid metabolic process (GO:0000038) | 2.78098058 |
139 | protein activation cascade (GO:0072376) | 2.77093481 |
140 | interferon-gamma production (GO:0032609) | 2.76673867 |
141 | T-helper cell differentiation (GO:0042093) | 2.76359240 |
142 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.76359240 |
143 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.75962908 |
144 | regulation of interleukin-12 production (GO:0032655) | 2.75934200 |
145 | regulation of interleukin-6 production (GO:0032675) | 2.75499552 |
146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75477105 |
147 | detection of molecule of bacterial origin (GO:0032490) | 2.74969881 |
148 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73196329 |
149 | amino-acid betaine metabolic process (GO:0006577) | 2.72790678 |
150 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.72435922 |
151 | serine family amino acid catabolic process (GO:0009071) | 2.72260008 |
152 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.71738775 |
153 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.71546897 |
154 | negative regulation of lipid storage (GO:0010888) | 2.71414468 |
155 | negative regulation of interleukin-1 production (GO:0032692) | 2.70971261 |
156 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.70894292 |
157 | amyloid precursor protein catabolic process (GO:0042987) | 2.70710533 |
158 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.69551393 |
159 | negative regulation of innate immune response (GO:0045824) | 2.69230175 |
160 | negative regulation of hemostasis (GO:1900047) | 2.68253461 |
161 | negative regulation of blood coagulation (GO:0030195) | 2.68253461 |
162 | response to laminar fluid shear stress (GO:0034616) | 2.67274158 |
163 | phospholipid homeostasis (GO:0055091) | 2.66830694 |
164 | glutamate metabolic process (GO:0006536) | 2.65560115 |
165 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.65073843 |
166 | alpha-amino acid catabolic process (GO:1901606) | 2.65067669 |
167 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.64594181 |
168 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.64038463 |
169 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.64038463 |
170 | response to nitrosative stress (GO:0051409) | 2.63777068 |
171 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.63342883 |
172 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.62650483 |
173 | detection of other organism (GO:0098543) | 2.62563849 |
174 | response to host immune response (GO:0052572) | 2.62120112 |
175 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62120112 |
176 | regulation of tolerance induction (GO:0002643) | 2.62094219 |
177 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62078166 |
178 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.61788036 |
179 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.60605716 |
180 | complement activation (GO:0006956) | 2.60266828 |
181 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59915805 |
182 | positive regulation of lipid catabolic process (GO:0050996) | 2.59645900 |
183 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.59625426 |
184 | sterol biosynthetic process (GO:0016126) | 2.59585378 |
185 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59374642 |
186 | positive regulation of isotype switching (GO:0045830) | 2.59239729 |
187 | positive regulation of tolerance induction (GO:0002645) | 2.59130058 |
188 | lipid homeostasis (GO:0055088) | 2.57916147 |
189 | T cell migration (GO:0072678) | 2.57483890 |
190 | regulation of plasminogen activation (GO:0010755) | 2.57269114 |
191 | positive regulation of B cell mediated immunity (GO:0002714) | 2.57083541 |
192 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.57083541 |
193 | aldehyde catabolic process (GO:0046185) | 2.56945999 |
194 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56667348 |
195 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.56612116 |
196 | positive regulation of type 2 immune response (GO:0002830) | 2.56058327 |
197 | glucuronate metabolic process (GO:0019585) | 2.55436305 |
198 | uronic acid metabolic process (GO:0006063) | 2.55436305 |
199 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.54616946 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.19573130 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.42753354 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.62134326 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.52609590 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.73326059 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.67278606 |
7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.05767284 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.92565728 |
9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.92214702 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.72071963 |
11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50200026 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.48608058 |
13 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42633416 |
14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42094592 |
15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31204733 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21335644 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17399031 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16724734 |
19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.15705066 |
20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09741444 |
21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.02307634 |
22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99309660 |
23 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97018494 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93860253 |
25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92804851 |
26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.89026244 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84665532 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84658406 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 1.84602962 |
30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82931063 |
31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82029481 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76231203 |
33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.68462733 |
34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68109276 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67000139 |
36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65054965 |
37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63148552 |
38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60821593 |
39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57430955 |
40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56285728 |
41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55041954 |
42 | MYC_22102868_ChIP-Seq_BL_Human | 1.54534813 |
43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54483199 |
44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52348574 |
45 | * MAF_26560356_Chip-Seq_TH2_Human | 1.50425435 |
46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48296128 |
47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47404134 |
48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46663275 |
49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42499993 |
50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40039198 |
51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36187159 |
52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36087478 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32670415 |
54 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30716325 |
55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30005433 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29993575 |
57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28696380 |
58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28656636 |
59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28535841 |
60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27263803 |
61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26787876 |
62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23584883 |
63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23072742 |
64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22166787 |
65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21505880 |
66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20735525 |
67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20146544 |
68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20083103 |
69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19176916 |
70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18901220 |
71 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.18523838 |
72 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16354567 |
73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15920565 |
74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15698649 |
75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14904391 |
76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14644615 |
77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13255798 |
78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13113206 |
79 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12240452 |
80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12097118 |
81 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12072576 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11961615 |
83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10971201 |
84 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10950506 |
85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07468278 |
86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07433598 |
87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07192381 |
88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07068463 |
89 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05507077 |
90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05015316 |
91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04451007 |
92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04261809 |
93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03670658 |
94 | MAF_26560356_Chip-Seq_TH1_Human | 1.03574295 |
95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03456373 |
96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02982197 |
97 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02643675 |
98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02539000 |
99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01949764 |
100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01782996 |
101 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01411396 |
102 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00842012 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97696971 |
104 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97599277 |
105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96992510 |
106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95436265 |
107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93067608 |
108 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91752313 |
109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91520313 |
110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91476891 |
111 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91224107 |
112 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90757422 |
113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90196131 |
114 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.90077378 |
115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89570531 |
116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89532172 |
117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88901816 |
118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88855283 |
119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88606745 |
120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88526807 |
121 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.88204184 |
122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87843873 |
123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87535821 |
124 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.87321286 |
125 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86743348 |
126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86663981 |
127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85127097 |
128 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84820763 |
129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84230932 |
130 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83819628 |
131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82761555 |
132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82741310 |
133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82741310 |
134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82491460 |
135 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81296173 |
136 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.80733538 |
137 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.80733538 |
138 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.80733538 |
139 | MYB_26560356_Chip-Seq_TH1_Human | 0.80660018 |
140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80128322 |
141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79367041 |
142 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78317757 |
143 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78317757 |
144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76598119 |
145 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76136982 |
146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76046994 |
147 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75852514 |
148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75527972 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.57647879 |
2 | MP0005360_urolithiasis | 4.75170246 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.38050764 |
4 | MP0005365_abnormal_bile_salt | 4.08754352 |
5 | MP0009840_abnormal_foam_cell | 3.68956646 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.43289282 |
7 | MP0003252_abnormal_bile_duct | 3.13045833 |
8 | MP0003806_abnormal_nucleotide_metabolis | 2.85698332 |
9 | MP0003724_increased_susceptibility_to | 2.49245582 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.40904538 |
11 | MP0009278_abnormal_bone_marrow | 2.25171469 |
12 | MP0010329_abnormal_lipoprotein_level | 2.23402129 |
13 | MP0002138_abnormal_hepatobiliary_system | 2.08042462 |
14 | MP0003436_decreased_susceptibility_to | 2.06074249 |
15 | MP0005083_abnormal_biliary_tract | 2.04527618 |
16 | MP0003303_peritoneal_inflammation | 2.04252879 |
17 | MP0005451_abnormal_body_composition | 2.01271448 |
18 | MP0003195_calcinosis | 2.00260172 |
19 | MP0005167_abnormal_blood-brain_barrier | 1.99033387 |
20 | MP0000609_abnormal_liver_physiology | 1.92436388 |
21 | MP0006082_CNS_inflammation | 1.85706840 |
22 | MP0003300_gastrointestinal_ulcer | 1.80083647 |
23 | MP0004947_skin_inflammation | 1.79209852 |
24 | MP0003172_abnormal_lysosome_physiology | 1.76899179 |
25 | MP0001666_abnormal_nutrient_absorption | 1.76830358 |
26 | MP0001851_eye_inflammation | 1.74962436 |
27 | MP0005332_abnormal_amino_acid | 1.68889500 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.68151743 |
29 | MP0004381_abnormal_hair_follicle | 1.60643889 |
30 | MP0005387_immune_system_phenotype | 1.58785403 |
31 | MP0001790_abnormal_immune_system | 1.58785403 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.58058478 |
33 | MP0003453_abnormal_keratinocyte_physiol | 1.57064519 |
34 | MP0001873_stomach_inflammation | 1.55280634 |
35 | MP0000716_abnormal_immune_system | 1.53751972 |
36 | MP0005310_abnormal_salivary_gland | 1.50684768 |
37 | MP0000920_abnormal_myelination | 1.49549121 |
38 | MP0003828_pulmonary_edema | 1.49474932 |
39 | MP0002419_abnormal_innate_immunity | 1.45635826 |
40 | MP0005000_abnormal_immune_tolerance | 1.45286928 |
41 | MP0004019_abnormal_vitamin_homeostasis | 1.43627218 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.41093512 |
43 | MP0001545_abnormal_hematopoietic_system | 1.41093512 |
44 | MP0003690_abnormal_glial_cell | 1.40572092 |
45 | MP0000604_amyloidosis | 1.38737827 |
46 | MP0008004_abnormal_stomach_pH | 1.37418012 |
47 | MP0002398_abnormal_bone_marrow | 1.34829185 |
48 | MP0008961_abnormal_basal_metabolism | 1.27141682 |
49 | MP0004510_myositis | 1.26489525 |
50 | MP0010368_abnormal_lymphatic_system | 1.25520543 |
51 | MP0008469_abnormal_protein_level | 1.25128768 |
52 | MP0001533_abnormal_skeleton_physiology | 1.24637732 |
53 | MP0000858_altered_metastatic_potential | 1.24508883 |
54 | MP0002933_joint_inflammation | 1.23335009 |
55 | MP0002723_abnormal_immune_serum | 1.23076332 |
56 | MP0003868_abnormal_feces_composition | 1.19558372 |
57 | MP0005025_abnormal_response_to | 1.18228106 |
58 | MP0001800_abnormal_humoral_immune | 1.18198376 |
59 | MP0000689_abnormal_spleen_morphology | 1.15582681 |
60 | MP0002429_abnormal_blood_cell | 1.15348857 |
61 | MP0009785_altered_susceptibility_to | 1.14997392 |
62 | MP0002254_reproductive_system_inflammat | 1.14679766 |
63 | MP0002796_impaired_skin_barrier | 1.14172057 |
64 | MP0001501_abnormal_sleep_pattern | 1.14069091 |
65 | MP0001243_abnormal_dermal_layer | 1.12579498 |
66 | MP0005319_abnormal_enzyme/_coenzyme | 1.12231043 |
67 | MP0001853_heart_inflammation | 1.12114399 |
68 | MP0006054_spinal_hemorrhage | 1.12090329 |
69 | MP0010234_abnormal_vibrissa_follicle | 1.11173476 |
70 | MP0002332_abnormal_exercise_endurance | 1.09731373 |
71 | MP0001845_abnormal_inflammatory_respons | 1.09207344 |
72 | MP0002722_abnormal_immune_system | 1.08254893 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.06711472 |
74 | MP0002277_abnormal_respiratory_mucosa | 1.06105162 |
75 | * MP0003448_altered_tumor_morphology | 1.06032281 |
76 | MP0009763_increased_sensitivity_to | 1.05609190 |
77 | MP0002405_respiratory_system_inflammati | 1.05133444 |
78 | MP0005058_abnormal_lysosome_morphology | 1.03858889 |
79 | MP0005464_abnormal_platelet_physiology | 1.03627725 |
80 | MP0002452_abnormal_antigen_presenting | 1.02145901 |
81 | MP0004883_abnormal_blood_vessel | 1.00616796 |
82 | MP0008260_abnormal_autophagy | 0.99962163 |
83 | MP0009333_abnormal_splenocyte_physiolog | 0.99617396 |
84 | MP0002998_abnormal_bone_remodeling | 0.99533997 |
85 | MP0000598_abnormal_liver_morphology | 0.99140872 |
86 | MP0001663_abnormal_digestive_system | 0.98753666 |
87 | MP0000685_abnormal_immune_system | 0.98494740 |
88 | MP0009643_abnormal_urine_homeostasis | 0.98342897 |
89 | MP0003329_amyloid_beta_deposits | 0.97346417 |
90 | MP0005166_decreased_susceptibility_to | 0.97079793 |
91 | MP0003091_abnormal_cell_migration | 0.96751051 |
92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95138226 |
93 | MP0002148_abnormal_hypersensitivity_rea | 0.95137831 |
94 | MP0005023_abnormal_wound_healing | 0.94803482 |
95 | MP0005671_abnormal_response_to | 0.93811710 |
96 | MP0003075_altered_response_to | 0.92875228 |
97 | MP0002060_abnormal_skin_morphology | 0.92487605 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 0.90750698 |
99 | MP0001835_abnormal_antigen_presentation | 0.90345749 |
100 | MP0003866_abnormal_defecation | 0.89750373 |
101 | MP0009764_decreased_sensitivity_to | 0.87865708 |
102 | MP0003279_aneurysm | 0.86389474 |
103 | MP0001819_abnormal_immune_cell | 0.86061542 |
104 | MP0002420_abnormal_adaptive_immunity | 0.85871083 |
105 | MP0005670_abnormal_white_adipose | 0.85399009 |
106 | MP0003646_muscle_fatigue | 0.84911733 |
107 | MP0010678_abnormal_skin_adnexa | 0.84281290 |
108 | MP0000249_abnormal_blood_vessel | 0.83165079 |
109 | MP0001216_abnormal_epidermal_layer | 0.83158926 |
110 | MP0010155_abnormal_intestine_physiology | 0.83005023 |
111 | MP0003045_fibrosis | 0.82899424 |
112 | MP0003763_abnormal_thymus_physiology | 0.81395999 |
113 | MP0000703_abnormal_thymus_morphology | 0.79680687 |
114 | MP0008873_increased_physiological_sensi | 0.79514597 |
115 | MP0003795_abnormal_bone_structure | 0.76977575 |
116 | MP0005164_abnormal_response_to | 0.75982135 |
117 | MP0001881_abnormal_mammary_gland | 0.75483772 |
118 | MP0001542_abnormal_bone_strength | 0.75152604 |
119 | MP0000579_abnormal_nail_morphology | 0.74561763 |
120 | MP0004185_abnormal_adipocyte_glucose | 0.73451682 |
121 | MP0003186_abnormal_redox_activity | 0.72886919 |
122 | MP0009053_abnormal_anal_canal | 0.72217681 |
123 | MP0004808_abnormal_hematopoietic_stem | 0.71589111 |
124 | MP0009765_abnormal_xenobiotic_induced | 0.70003779 |
125 | MP0000647_abnormal_sebaceous_gland | 0.69670852 |
126 | MP0005076_abnormal_cell_differentiation | 0.69328798 |
127 | MP0005390_skeleton_phenotype | 0.68773122 |
128 | MP0005408_hypopigmentation | 0.68340970 |
129 | MP0001661_extended_life_span | 0.68182566 |
130 | MP0003566_abnormal_cell_adhesion | 0.67013692 |
131 | MP0000343_altered_response_to | 0.65903363 |
132 | MP0004264_abnormal_extraembryonic_tissu | 0.65573431 |
133 | MP0002098_abnormal_vibrissa_morphology | 0.65253220 |
134 | MP0009642_abnormal_blood_homeostasis | 0.64152725 |
135 | MP0002132_abnormal_respiratory_system | 0.56301397 |
136 | MP0005381_digestive/alimentary_phenotyp | 0.54509743 |
137 | MP0008874_decreased_physiological_sensi | 0.53507304 |
138 | MP0002877_abnormal_melanocyte_morpholog | 0.52296906 |
139 | MP0002006_tumorigenesis | 0.51261381 |
140 | MP0003183_abnormal_peptide_metabolism | 0.50480671 |
141 | MP0002653_abnormal_ependyma_morphology | 0.48999803 |
142 | MP0005535_abnormal_body_temperature | 0.48723834 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.07916828 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.96545710 |
3 | Deep venous thrombosis (HP:0002625) | 5.77182616 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.58978021 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.58978021 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.58978021 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.34425961 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 5.29786067 |
9 | Xanthomatosis (HP:0000991) | 5.25379724 |
10 | Joint hemorrhage (HP:0005261) | 5.00911212 |
11 | Myositis (HP:0100614) | 4.83982459 |
12 | Optic neuritis (HP:0100653) | 4.79176551 |
13 | Retrobulbar optic neuritis (HP:0100654) | 4.79176551 |
14 | Orchitis (HP:0100796) | 4.75647243 |
15 | Abnormality of macrophages (HP:0004311) | 4.74734429 |
16 | Complement deficiency (HP:0004431) | 4.30679678 |
17 | Hypobetalipoproteinemia (HP:0003563) | 4.27676160 |
18 | Hyperlipoproteinemia (HP:0010980) | 4.24272115 |
19 | Recurrent abscess formation (HP:0002722) | 3.92949617 |
20 | Mediastinal lymphadenopathy (HP:0100721) | 3.86495086 |
21 | Autoimmune thrombocytopenia (HP:0001973) | 3.86112511 |
22 | Increased cerebral lipofuscin (HP:0011813) | 3.78751532 |
23 | Myocardial infarction (HP:0001658) | 3.70847220 |
24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.64929225 |
25 | Epidermoid cyst (HP:0200040) | 3.62420159 |
26 | Stomatitis (HP:0010280) | 3.50459931 |
27 | Loss of speech (HP:0002371) | 3.48670040 |
28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.43692764 |
29 | Keratoconjunctivitis sicca (HP:0001097) | 3.40966870 |
30 | Abnormality of complement system (HP:0005339) | 3.36268514 |
31 | Fat malabsorption (HP:0002630) | 3.33969005 |
32 | Keratoconjunctivitis (HP:0001096) | 3.32729160 |
33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.27618959 |
34 | Hypolipoproteinemia (HP:0010981) | 3.26597838 |
35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26519297 |
36 | Pulmonary infiltrates (HP:0002113) | 3.25635948 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22831643 |
38 | Pustule (HP:0200039) | 3.18332583 |
39 | Parakeratosis (HP:0001036) | 3.16666676 |
40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.16558733 |
41 | Eczematoid dermatitis (HP:0000976) | 3.14295948 |
42 | Systemic lupus erythematosus (HP:0002725) | 3.13923615 |
43 | Vasculitis (HP:0002633) | 3.11816523 |
44 | Hypoalphalipoproteinemia (HP:0003233) | 3.04661500 |
45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.03590258 |
46 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.03590258 |
47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.03590258 |
48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.96528968 |
49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.95786467 |
50 | Hemoptysis (HP:0002105) | 2.89501733 |
51 | Hematochezia (HP:0002573) | 2.89480204 |
52 | Abnormality of methionine metabolism (HP:0010901) | 2.86200348 |
53 | Increased IgE level (HP:0003212) | 2.80827463 |
54 | Interstitial pulmonary disease (HP:0006530) | 2.79322192 |
55 | Gingival bleeding (HP:0000225) | 2.78718791 |
56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74945089 |
57 | Mucopolysacchariduria (HP:0008155) | 2.74945089 |
58 | Amyloidosis (HP:0011034) | 2.73579293 |
59 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.69820670 |
60 | Neurofibrillary tangles (HP:0002185) | 2.69301030 |
61 | Steatorrhea (HP:0002570) | 2.67044687 |
62 | Increased IgM level (HP:0003496) | 2.64964093 |
63 | Vascular calcification (HP:0004934) | 2.62335351 |
64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.59279875 |
65 | Glomerulonephritis (HP:0000099) | 2.58189544 |
66 | Autoimmune hemolytic anemia (HP:0001890) | 2.57558722 |
67 | Menorrhagia (HP:0000132) | 2.57344192 |
68 | Hypoglycemic seizures (HP:0002173) | 2.54644103 |
69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53458147 |
70 | Leukocytosis (HP:0001974) | 2.53250705 |
71 | Axonal loss (HP:0003447) | 2.52098671 |
72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51253676 |
73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51253676 |
74 | Recurrent viral infections (HP:0004429) | 2.50333689 |
75 | T lymphocytopenia (HP:0005403) | 2.49186999 |
76 | Gastrointestinal infarctions (HP:0005244) | 2.47929956 |
77 | Spontaneous abortion (HP:0005268) | 2.46802358 |
78 | Hyperammonemia (HP:0001987) | 2.46660486 |
79 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.45919154 |
80 | Abnormality of T cell number (HP:0011839) | 2.45791345 |
81 | Obstructive lung disease (HP:0006536) | 2.45282320 |
82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45282320 |
83 | Gangrene (HP:0100758) | 2.44865849 |
84 | Peripheral demyelination (HP:0011096) | 2.43958259 |
85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39726028 |
86 | Meningitis (HP:0001287) | 2.37763220 |
87 | Disinhibition (HP:0000734) | 2.36450167 |
88 | Esophageal varix (HP:0002040) | 2.35500227 |
89 | Hypoglycemic coma (HP:0001325) | 2.34869254 |
90 | Abnormality of iron homeostasis (HP:0011031) | 2.34356342 |
91 | Hypercholesterolemia (HP:0003124) | 2.33557268 |
92 | Hypergammaglobulinemia (HP:0010702) | 2.31607130 |
93 | Increased serum ferritin (HP:0003281) | 2.30738000 |
94 | Mutism (HP:0002300) | 2.29866980 |
95 | Cardiovascular calcification (HP:0011915) | 2.27387079 |
96 | Peripheral hypomyelination (HP:0007182) | 2.26372779 |
97 | Keratitis (HP:0000491) | 2.24497107 |
98 | Ketosis (HP:0001946) | 2.22656359 |
99 | Pulmonary embolism (HP:0002204) | 2.19627945 |
100 | Encephalitis (HP:0002383) | 2.17851166 |
101 | Urticaria (HP:0001025) | 2.15671816 |
102 | Recurrent bacterial skin infections (HP:0005406) | 2.15359436 |
103 | Anorexia (HP:0002039) | 2.13753035 |
104 | Polyneuropathy (HP:0001271) | 2.12619370 |
105 | Hypophosphatemic rickets (HP:0004912) | 2.12269267 |
106 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.10230273 |
107 | Gingivitis (HP:0000230) | 2.09181875 |
108 | Abnormal tarsal ossification (HP:0008369) | 2.08198875 |
109 | Hydroxyprolinuria (HP:0003080) | 2.07766040 |
110 | Abnormality of proline metabolism (HP:0010907) | 2.07766040 |
111 | Cerebral inclusion bodies (HP:0100314) | 2.07181483 |
112 | Spontaneous hematomas (HP:0007420) | 2.06714145 |
113 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06334917 |
114 | Pancreatitis (HP:0001733) | 2.04407889 |
115 | Vacuolated lymphocytes (HP:0001922) | 2.02393500 |
116 | Hemorrhage of the eye (HP:0011885) | 2.00625287 |
117 | Skin nodule (HP:0200036) | 1.98960115 |
118 | Symptomatic seizures (HP:0011145) | 1.98504748 |
119 | Disproportionate tall stature (HP:0001519) | 1.98055747 |
120 | Mitral stenosis (HP:0001718) | 1.97653170 |
121 | Stomach cancer (HP:0012126) | 1.96426106 |
122 | Abnormality of the pericardium (HP:0001697) | 1.96004484 |
123 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95893602 |
124 | Arterial thrombosis (HP:0004420) | 1.95042335 |
125 | Spondylolisthesis (HP:0003302) | 1.94952933 |
126 | Recurrent skin infections (HP:0001581) | 1.94435263 |
127 | Abnormality of the pleura (HP:0002103) | 1.94411932 |
128 | Onion bulb formation (HP:0003383) | 1.93930949 |
129 | Restrictive lung disease (HP:0002091) | 1.93748111 |
130 | Eosinophilia (HP:0001880) | 1.93210791 |
131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93034192 |
132 | Abnormality of T cells (HP:0002843) | 1.92038381 |
133 | Arthralgia (HP:0002829) | 1.91350123 |
134 | Joint swelling (HP:0001386) | 1.90760470 |
135 | Neuronal loss in central nervous system (HP:0002529) | 1.90578264 |
136 | Lymphopenia (HP:0001888) | 1.89375064 |
137 | Elevated alkaline phosphatase (HP:0003155) | 1.89008087 |
138 | Alveolar cell carcinoma (HP:0006519) | 1.88996226 |
139 | Slow saccadic eye movements (HP:0000514) | 1.88212341 |
140 | Gastrointestinal stroma tumor (HP:0100723) | 1.88061854 |
141 | Progressive neurologic deterioration (HP:0002344) | 1.87783201 |
142 | Thrombophlebitis (HP:0004418) | 1.87771236 |
143 | Abnormal gallbladder morphology (HP:0012437) | 1.87519959 |
144 | Peritonitis (HP:0002586) | 1.87248507 |
145 | Granulocytopenia (HP:0001913) | 1.86127255 |
146 | Hyperbilirubinemia (HP:0002904) | 1.85336020 |
147 | Ileus (HP:0002595) | 1.84992622 |
148 | Paraparesis (HP:0002385) | 1.84505248 |
149 | Rickets (HP:0002748) | 1.84046378 |
150 | Petechiae (HP:0000967) | 1.83586856 |
151 | Vertigo (HP:0002321) | 1.81512790 |
152 | Glomerulopathy (HP:0100820) | 1.81082225 |
153 | Hepatocellular carcinoma (HP:0001402) | 1.81037511 |
154 | Purpura (HP:0000979) | 1.80746419 |
155 | Abnormality of the endocardium (HP:0004306) | 1.80639195 |
156 | Spastic paraparesis (HP:0002313) | 1.80555968 |
157 | Increased CSF protein (HP:0002922) | 1.79750988 |
158 | Thick nail (HP:0001805) | 1.79544638 |
159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79538278 |
160 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79264686 |
161 | Protuberant abdomen (HP:0001538) | 1.79133554 |
162 | Erythroderma (HP:0001019) | 1.78559311 |
163 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.78433728 |
164 | Anhidrosis (HP:0000970) | 1.78246262 |
165 | Irritability (HP:0000737) | 1.77830951 |
166 | Dysostosis multiplex (HP:0000943) | 1.77663728 |
167 | Sensorimotor neuropathy (HP:0007141) | 1.77147323 |
168 | Albinism (HP:0001022) | 1.76067751 |
169 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75258066 |
170 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75197955 |
171 | Abnormality of glycine metabolism (HP:0010895) | 1.75192345 |
172 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75192345 |
173 | Abnormality of eosinophils (HP:0001879) | 1.75185904 |
174 | Nuclear cataract (HP:0100018) | 1.75062905 |
175 | Recurrent fungal infections (HP:0002841) | 1.74633161 |
176 | Abnormal cartilage morphology (HP:0002763) | 1.74478467 |
177 | Abnormality of purine metabolism (HP:0004352) | 1.73977389 |
178 | Autoamputation (HP:0001218) | 1.72648294 |
179 | Increased mean platelet volume (HP:0011877) | 1.71470781 |
180 | Hyperglycinemia (HP:0002154) | 1.71035961 |
181 | Episodic fever (HP:0001954) | 1.69036007 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHB1 | 3.89303637 |
2 | MAP3K14 | 3.35295589 |
3 | ERN1 | 3.27952919 |
4 | MAP4K1 | 3.10923096 |
5 | MAPK15 | 3.03171949 |
6 | FGFR4 | 2.96170715 |
7 | EPHA3 | 2.56612425 |
8 | TXK | 2.13574240 |
9 | PRPF4B | 2.07272549 |
10 | ITK | 2.06438488 |
11 | MAP3K3 | 2.05420762 |
12 | GRK7 | 1.96945497 |
13 | STK39 | 1.92760872 |
14 | EPHA2 | 1.91774995 |
15 | TBK1 | 1.86455742 |
16 | TAOK2 | 1.85907881 |
17 | ADRBK2 | 1.85327546 |
18 | RIPK4 | 1.84086916 |
19 | TSSK6 | 1.83544728 |
20 | MET | 1.72084489 |
21 | PBK | 1.70669049 |
22 | ERBB4 | 1.67935482 |
23 | TGFBR2 | 1.64598997 |
24 | CSK | 1.57612230 |
25 | MATK | 1.57267286 |
26 | STK10 | 1.50035124 |
27 | IRAK3 | 1.48155204 |
28 | IKBKB | 1.47033383 |
29 | TYK2 | 1.44405708 |
30 | SIK3 | 1.44053735 |
31 | ZAP70 | 1.43811856 |
32 | NLK | 1.43326034 |
33 | MAP2K2 | 1.37291405 |
34 | MAPK7 | 1.34471650 |
35 | MAP2K3 | 1.33675683 |
36 | TAOK3 | 1.31665446 |
37 | IKBKE | 1.21017179 |
38 | CDK12 | 1.20931397 |
39 | GSK3A | 1.20513156 |
40 | CHUK | 1.20439909 |
41 | DDR2 | 1.15740660 |
42 | TESK2 | 1.14990044 |
43 | MARK3 | 1.14882929 |
44 | CDC42BPA | 1.14667796 |
45 | SIK1 | 1.14004397 |
46 | SIK2 | 1.13421246 |
47 | MOS | 1.12989980 |
48 | IRAK1 | 1.11520308 |
49 | SYK | 1.11187044 |
50 | MAPKAPK5 | 1.10631285 |
51 | JAK1 | 1.10613493 |
52 | PTK6 | 1.09987881 |
53 | FES | 1.09439907 |
54 | KDR | 1.09023807 |
55 | OXSR1 | 1.05811657 |
56 | IRAK2 | 1.05731776 |
57 | MST4 | 1.05326354 |
58 | RPS6KA4 | 1.04904168 |
59 | NME2 | 1.03831913 |
60 | BLK | 1.00149042 |
61 | LYN | 0.99003244 |
62 | KIT | 0.97451788 |
63 | CAMKK2 | 0.97081083 |
64 | CSF1R | 0.96934408 |
65 | BCKDK | 0.96210793 |
66 | BMPR2 | 0.94293884 |
67 | JAK2 | 0.93980621 |
68 | JAK3 | 0.93978592 |
69 | BCR | 0.92557697 |
70 | CSNK1A1L | 0.92032723 |
71 | TRPM7 | 0.91940347 |
72 | PKN1 | 0.90574307 |
73 | FGR | 0.90243701 |
74 | TNK2 | 0.89918349 |
75 | FGFR2 | 0.88069943 |
76 | MAP3K11 | 0.87899004 |
77 | MARK2 | 0.85738027 |
78 | TAOK1 | 0.85159627 |
79 | PRKCQ | 0.83321309 |
80 | ABL2 | 0.81044865 |
81 | GRK6 | 0.79290926 |
82 | PRKD2 | 0.76301072 |
83 | MAP3K13 | 0.75107784 |
84 | PTK2 | 0.74729154 |
85 | MAP3K1 | 0.74305108 |
86 | HCK | 0.73917276 |
87 | WNK4 | 0.73850107 |
88 | EPHB2 | 0.73039479 |
89 | LCK | 0.72790368 |
90 | BMX | 0.72482485 |
91 | TRIB3 | 0.71401957 |
92 | NEK6 | 0.67063851 |
93 | CAMKK1 | 0.66721096 |
94 | RPS6KA6 | 0.65877709 |
95 | HIPK2 | 0.65074140 |
96 | MAP3K5 | 0.64931214 |
97 | IRAK4 | 0.64769114 |
98 | FGFR3 | 0.64208591 |
99 | RPS6KC1 | 0.63211765 |
100 | RPS6KL1 | 0.63211765 |
101 | PRKCH | 0.62277752 |
102 | MAPK4 | 0.61229612 |
103 | INSRR | 0.60998404 |
104 | CSNK1G1 | 0.59378873 |
105 | DYRK1B | 0.58829350 |
106 | STK24 | 0.58156970 |
107 | RPS6KA5 | 0.56906265 |
108 | MTOR | 0.56629246 |
109 | MAP2K6 | 0.56627742 |
110 | CSNK1G3 | 0.55297857 |
111 | TLK1 | 0.50526530 |
112 | CLK1 | 0.49588780 |
113 | ERBB2 | 0.49261923 |
114 | MAPK12 | 0.49114408 |
115 | MST1R | 0.48743977 |
116 | PDGFRB | 0.47426881 |
117 | ICK | 0.46000129 |
118 | CAMK4 | 0.45795812 |
119 | ABL1 | 0.45686813 |
120 | MELK | 0.44992915 |
121 | EGFR | 0.44335935 |
122 | PDK1 | 0.43791405 |
123 | PIM1 | 0.43425003 |
124 | LIMK1 | 0.43253701 |
125 | INSR | 0.41650667 |
126 | TYRO3 | 0.40538934 |
127 | RPS6KA2 | 0.39900601 |
128 | MAPKAPK2 | 0.39505722 |
129 | BRD4 | 0.39173058 |
130 | TEC | 0.38969944 |
131 | RIPK1 | 0.38244806 |
132 | MAP3K7 | 0.38160103 |
133 | CAMK2G | 0.37839117 |
134 | PAK2 | 0.37498643 |
135 | WNK1 | 0.37230507 |
136 | BTK | 0.36043930 |
137 | MAP2K1 | 0.36001195 |
138 | DAPK2 | 0.35929341 |
139 | PRKD1 | 0.35344937 |
140 | PIM2 | 0.35082506 |
141 | NTRK1 | 0.34715234 |
142 | RPS6KA1 | 0.30419983 |
143 | PDPK1 | 0.30083143 |
144 | DYRK3 | 0.28621883 |
145 | GRK1 | 0.28469291 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90380930 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.07573429 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88939311 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66279942 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.57491670 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49250047 |
7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.48996904 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47645128 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39900654 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26758112 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25496378 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.20677794 |
13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87129578 |
14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.85161118 |
15 | * Tuberculosis_Homo sapiens_hsa05152 | 1.76890548 |
16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.63838194 |
17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61842312 |
18 | Peroxisome_Homo sapiens_hsa04146 | 1.61152505 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61135003 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59953611 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59234279 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.58895366 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58592113 |
24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57445305 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55435788 |
26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52708586 |
27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52238606 |
28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51515967 |
29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49127017 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48682296 |
31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47938712 |
32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45566437 |
33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.43567804 |
34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41811112 |
35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37611168 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33237500 |
37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32168203 |
38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31764123 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30429361 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30341131 |
41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30049595 |
42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28674620 |
43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28327212 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26152778 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.25670901 |
46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23652354 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20168771 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.18929177 |
49 | Bile secretion_Homo sapiens_hsa04976 | 1.16077692 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13563209 |
51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13303453 |
52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10192216 |
53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09952968 |
54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08394166 |
55 | Prion diseases_Homo sapiens_hsa05020 | 1.08252279 |
56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07041618 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06079280 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05669514 |
59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05379315 |
60 | Apoptosis_Homo sapiens_hsa04210 | 1.04760394 |
61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02387200 |
62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01888267 |
63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.01859957 |
64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00750893 |
65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99903239 |
66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96057078 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93159899 |
68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90899252 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89047925 |
70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88336825 |
71 | Malaria_Homo sapiens_hsa05144 | 0.83874230 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81737582 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80769723 |
74 | Bladder cancer_Homo sapiens_hsa05219 | 0.79164613 |
75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79125439 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78715457 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.77935543 |
78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77215472 |
79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75635491 |
80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71636778 |
81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71346000 |
82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71080551 |
83 | Lysosome_Homo sapiens_hsa04142 | 0.70522210 |
84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69613731 |
85 | Lysine degradation_Homo sapiens_hsa00310 | 0.68909472 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68079054 |
87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66938387 |
88 | Asthma_Homo sapiens_hsa05310 | 0.66172501 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65954867 |
90 | Pertussis_Homo sapiens_hsa05133 | 0.64633932 |
91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61817463 |
92 | Allograft rejection_Homo sapiens_hsa05330 | 0.61788923 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60276009 |
94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60132612 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59598387 |
96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59283288 |
97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58183764 |
98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56820693 |
99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56786155 |
100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56744404 |
101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55705656 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55560081 |
103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55497514 |
104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54119897 |
105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52088027 |
106 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52062411 |
107 | Hepatitis C_Homo sapiens_hsa05160 | 0.51505109 |
108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51462463 |
109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51162148 |
110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51015568 |
111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50429308 |
112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50147518 |
113 | Measles_Homo sapiens_hsa05162 | 0.49912729 |
114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49491808 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49374309 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.49268279 |
117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48069734 |
118 | Legionellosis_Homo sapiens_hsa05134 | 0.48022499 |
119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47413198 |
120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47146371 |
121 | Platelet activation_Homo sapiens_hsa04611 | 0.46448228 |
122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46036630 |
123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45098652 |
124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45092077 |
125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43753511 |
126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43388732 |
127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41794626 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41572474 |
129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41410429 |
130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40984564 |
131 | Salmonella infection_Homo sapiens_hsa05132 | 0.40710685 |
132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40613828 |
133 | Endocytosis_Homo sapiens_hsa04144 | 0.40487381 |
134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40147920 |
135 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38725731 |
136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38564920 |
137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38513605 |
138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38511869 |
139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35641053 |
140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35062867 |
141 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34603339 |
142 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34394706 |
143 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33525671 |
144 | Phagosome_Homo sapiens_hsa04145 | 0.32556019 |
145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31548754 |
146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31451796 |
147 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31256855 |
148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30451885 |
149 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29580128 |
150 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29479678 |
151 | Shigellosis_Homo sapiens_hsa05131 | 0.28581647 |
152 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28233836 |
153 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26215145 |
154 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24155224 |
155 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23835862 |
156 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23724139 |
157 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23672133 |
158 | Prostate cancer_Homo sapiens_hsa05215 | 0.23218382 |